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Coronary heart disease (CHD) continues to be a ma-
jor cause of death in the United States and other devel-
oped countries. Elevated plasma low-density lipopro-
tein (LDL) cholesterol concentration is a primary risk 
factor for CHD; thus, treatment strategies for CHD often 
involve drug therapy as well as dietary and other life-
style changes that reduce plasma LDL cholesterol con-
centration [1].
There is particular interest among researchers and 
consumers in natural bioactive substances that lower 
plasma LDL cholesterol concentration. Clinical stud-
ies have repeatedly shown that plant sterols (PS), when 
consumed at 1 to 3 g/d, significantly reduce plasma 
LDL cholesterol concentration [2, 3]. Plant sterols can 
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Abstract
Plant sterol esters (PSE) reduce plasma low-density lipoprotein cholesterol concentration by inhibiting choles-
terol absorption. Previous work in our laboratory indicated that PSE containing stearic acid (SA), compared to 
linoleic acid, were significantly more effective at reducing cholesterol absorption. We tested the cholesterol low-
ering properties of PSE containing fatty acids from beef tallow, a natural and abundant source of SA. Male ham-
sters were fed diets containing 0.0%, 0.5%, 1.0%, or 5.0% beef tallow PSE for 4 weeks. Dose-dependent reduc-
tions (P < .05) were observed in cholesterol absorption, liver esterified cholesterol, and plasma nonhigh-density 
lipoprotein cholesterol concentration; hamsters fed 5.0% PSE exhibited reductions of 56%, 98%, and 38%, re-
spectively, compared to controls. Concurrent increases (P < .05) in fecal sterol excretion were also observed. In 
a second hamster study, the cholesterol-lowering properties of beef tallow PSE were compared to hamsters fed 
molar equivalents of free plant sterols (PS) and free SA. Beef tallow PSE were significantly more effective at re-
ducing liver and plasma cholesterol concentrations than PS and SA consumed individually. Whether PS and SA 
act through independent or synergistic mechanisms will require further research, although the present findings 
support the use of dietary PSE containing beef tallow fatty acids in the management of hypercholesterolemia.
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also be used as a secondary therapy; the combination of 
PS and statin medication is more effective than doubling 
the statin dose [3]. Accordingly, the National Choles-
terol Education Program [4] recommends 2 g/d of PS or 
stanol esters as a therapeutic option for reducing plasma 
LDL cholesterol concentration.
Plant sterols elicit their cholesterol lowering response 
by interfering with intestinal absorption of cholesterol 
[5]. However, as high melting solids with limited solu-
bility in both water and oil, pure PS have yielded incon-
sistent results in animal and human studies [6]. Matt-
son and coworkers [7, 8] discovered that esterifying PS 
with long-chain fatty acids increased their solubility in 
oil from about 2% to more than 20% and that esterifi-
cation did not impair their ability to inhibit cholesterol 
absorption. Commercial synthesis of plant sterol esters 
(PSE) uses common vegetable oils, such as canola, soy-
bean, and sunflower, as the fatty acid source.
The extent to which the fatty acid moiety of PSE in-
fluences cholesterol absorption is vastly understudied. 
We recently discovered that hamsters consuming PSE 
enriched with stearic acid (SA), compared to linoleic 
acid, had significant reductions in both cholesterol ab-
sorption and plasma nonhigh-density lipoprotein (non-
HDL) cholesterol concentration [9]. We now report the 
results of 2 hamster feeding studies designed to further 
elucidate the role of the fatty acid moiety. Study 1 ex-
amined the dose response of PSE made with beef tallow 
fatty acids—an abundant source of SA—on plasma and 
liver lipid concentrations, cholesterol absorption, and 
sterol excretion. Study 2 compared the effects of beef tal-
low PSE vs consuming equivalent amounts of free PS 
and free SA.
2. Methods and Materials
2.1. Animals and diets
Two studies were conducted using male F1B Syr-
ian hamsters (BioBreeders, Watertown, Mass) weigh-
ing approximately 90 to 100 g. Upon arrival, the ham-
sters were randomly divided into treatment groups 
and given free access to food and water throughout 
both 4-week studies. Hamsters were housed individ-
ually in polycarbonate cages with sawdust bedding 
and kept in a humidity-controlled room at 25°C, us-
ing a 12-hour light/dark cycle for the duration of the 
study. All procedures were approved by the Institu-
tional Animal Care and Use Committee of the Univer-
sity of Nebraska.
In study 1, hamsters were fed a control diet devoid 
of PSE or diets containing 5, 10, or 50 g/kg PSE ester-
ified with fatty acids from beef tallow (Table 1). Corn-
starch was adjusted to accommodate the addition of 
PSE. In study 2, hamsters were fed a control diet de-
void of PSE (0% PSE) or diets containing 50 g/kg PS 
esterified with fatty acids from beef tallow (5% PSE) or 
30 g/kg free PS plus 20 g/kg free SA (3% PS + 2% SA) 
(Table 2). The control diet in study 2 contained 20 g/
kg beef tallow, which acted as a control for the 20 g/
kg of fatty acid consumed as a free moiety (3% PS + 
2% SA diet) or as part of the PSE compound (5% PSE 
diet). The control diet also contained 30 g/kg more cel-
lulose, which served as a nonabsorbable substitute for 
the 30 g/kg PS consumed as a free moiety or as PSE. 
The dietary protein source was lean ground beef pur-
chased at a local grocery store and freeze-dried at the 
Food Processing Center at the University of Nebraska. 
The freeze-dried beef was pulverized and sifted to 
provide a homogenous powder. The composition of 
freeze-dried beef for protein, fat, and ash was 64, 32, 
and 3 g/100 g, respectively. A high content of beef was 
used in all diets to approximate the macronutrient dis-
tribution of a high-protein, low-carbohydrate diet (eg, 
the Atkins diet), in which the primary protein source is 
animal protein. The energy distribution of protein, car-
bohydrate, and fat in the control diets was 32%, 41%, 
and 28% in study 1, and 34%, 37%, and 29% in study 2. 
The AIN-93 mineral mix, vitamin mix, and beef tallow 
were purchased from Dyets, Inc (Bethlehem, Pa). In-
gredients were combined and mechanically mixed; the 
beef tallow was first melted at low temperature before 
being added to the control diet in study 2. Diets were 
stored at −20°C.
Table 1. Composition of hamster diets containing PS esterified with 
fatty acids from beef tallow (PSE), study 1
 0.0% PSE  0.5% PSE  1.0% PSE  5.0% PSE  
 (g/kg) (g/kg) (g/kg) (g/kg)
Ground beefa 500 500 500 500
Cornstarch 255 250 245 205
Sucrose 100 100 100 100
PSE 0 5 10 50
Fiberb 50 50 50 50
Soybean oil 50 50 50 50
AIN-93 mineral mixc 35 35 35 35
AIN-93 vitamin mixc 10 10 10 10
a. Ninety percent lean, freeze-dried.
b. Solka-Floc 200 cellulose powder (International Fiber Corp., North 
Tonawanda, NY).
c. Reeves et al [10].
Table 2. Composition of hamster diets containing PS esterified with 
fatty acids from beef tallow (PSE) or free PS and free SA, study 2
 0% PSE 5% PSE  3% PS + 2% SA  
 (g/kg) (g/kg) (g/kg)
Ground beefa 500 500 500
Cornstarch 305 305 305
Sucrose 50 50 50
PSE – 50 –
Free PS – – 30
Free SA – – 20
Fiberb 80 50 50
Beef tallow 20 – –
AIN-93 mineral mixc 35 35 35
AIN-93 vitamin mixc 10 10 10
a. Ninety percent lean, freeze-dried.
b. Solka-Floc 200 cellulose powder.
c. Reeves et al [10].
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2.2. Plant sterol ester preparation
Unesterified (free) sterols from soybeans were obtained 
from Archer Daniels Midland Company (Decatur, Ill) 
and were composed of approximately 48% sitosterol, 
27% campesterol, and 21% stigmasterol as determined 
by gas chromatography using a DB-5 capillary column 
(Agilent, Wilmington, Del). Before esterification, free 
fatty acids were prepared from the beef tallow triglyc-
erides, then esterified to PS as previously described [9].
2.3. Experimental procedures
Body weight and food intake were recorded weekly. 
Cholesterol absorption efficiency was determined dur-
ing the third week, and feces were collected during the 
fourth week to quantify fecal neutral steroid and bile 
acid excretion. Food was removed on day 28, and the 
hamsters were euthanized on day 29 by carbon dioxide 
asphyxiation. The abdomen and thorax were opened by 
incision, and blood was collected by cardiac puncture. 
Plasma was obtained by centrifuging for 30 minutes at 
4°C at 2000 × g. The liver was perfused with saline via 
the hepatic portal vein to remove residual blood, and 
the liver was excised, weighed, and immediately frozen 
in liquid nitrogen.
Cholesterol absorption and fecal neutral steroids 
were measured as previously described [11]. Fecal bile 
acids were measured enzymatically (Wako Chemicals, 
Richmond, Va) after extraction and solubilization in Tri-
ton X-100 [12]. Liver lipids were determined as previ-
ously described [12], using enzymatic reagents for total 
cholesterol (Roche Diagnostics, Indianapolis, Ind), free 
cholesterol (Wako), and phospholipids (Wako). Liver 
esterified cholesterol was calculated as the difference be-
tween total and free cholesterol. Plasma total cholesterol 
was measured enzymatically (Roche); HDL cholesterol 
was quantified after precipitating apoB-containing lipo-
proteins (Precipitating Reagent 1335-250; Thermo Elec-
tron Corp, Louisville, Colo). Non-HDL cholesterol con-
centration was calculated as the difference between total 
and HDL cholesterol.
2.4. Statistical analyses
All data are expressed as means ± SEM. Treatment dif-
ferences were determined by 1-way analysis of variance, 
followed by the Tukey multiple comparison procedure 
to identify differences in treatment means. Analysis of 
variance on ranks was used for liver esterified choles-
terol concentration because of unequal variance. Differ-
ences were considered significant at P < .05. Data were 
analyzed using SigmaStat 3.0 (SPSS, Chicago, Ill).
3. Results
3.1. Study 1
Body weight gain and food intake were not significantly 
different among treatment groups. The overall mean 
body weight at the end of the study was 123 ± 1 g, and 
food intake was 6.3 ± 0.1 g/d.
Plasma non-HDL cholesterol concentration was sig-
nificantly reduced about 37% in hamsters fed 5.0% PSE 
compared to other treatments (Table 3). Non-HDL cho-
lesterol in hamsters fed 0.5% PSE and 1.0% PSE was not 
significantly different than controls, indicating that a 
higher dose PSE was required to elicit a significant re-
duction in non-HDL cholesterol. Plasma HDL choles-
terol concentration was highest in the control group, but 
was not significantly different among hamsters fed PSE. 
Liver free cholesterol concentration was significantly 
lower in hamsters fed PSE at all levels compared to con-
trol (0.0% PSE). Liver esterified cholesterol was incre-
mentally reduced as dietary PSE was increased, with the 
lowest concentration observed in hamsters fed 5.0% PSE. 
Table 3. Plasma cholesterol, liver weight, and liver lipid concentration in hamsters fed diets containing PS esterified with fatty acids from beef 
tallow (PSE), study 1
 0.0% PSE 0.5% PSE 1.0% PSE 5.0% PSE
Non-HDL cholesterol (mmol/L) 1.68 ± 0.15b 1.65 ± 0.13b 1.69 ± 0.09b 1.05 ± 0.09a
HDL cholesterol (mmol/L) 1.89 ± 0.10b 1.58 ± 0.07a 1.39 ± 0.04a 1.53 ± 0.07a
Liver weight (g/100 g body wt) 4.35 ± 0.06bc 4.50 ± 0.08c 4.18 ± 0.09ab 4.00 ± 0.06a
Liver free cholesterol (μmol/g) 9.67 ± 0.73b 6.62 ± 0.16a 6.21 ± 0.45a 5.03 ± 0.06a
Liver esterified cholesterol (μmol/g) 8.07 ± 1.38c 1.41 ± 0.25bc 0.72 ± 0.15ab 0.18 ± 0.04a
Liver phospholipid (μmol/g) 24.2 ± 0.4 23.3 ± 0.7 23.2 ± 1.2 22.4 ± 0.5
Means ± SEM (n = 11-12). Means within the same row having different superscripts are significantly different (P < .05).
Table 4. Cholesterol absorption and fecal sterol excretion in hamsters fed diets containing PS esterified with fatty acids from beef tallow 
(PSE), study 1
 0.0% PSE 0.5% PSE 1.0% PSE 5.0% PSE
Cholesterol absorption (%) 61.4 ± 1.9c 62.0 ± 3.3c 45.7 ± 3.0b 26.9 ± 2.2a
Fecal neutral sterol excretion (μmol/[d 100 g body wt]) 3.82 ± 0.42a 6.78 ± 0.14b 7.46 ± 0.43b 15.99 ± 0.29c
Fecal bile acid excretion (μmol/[d 100 g body wt]) 2.63 ± 0.12a 3.40 ± 0.26bc 3.60 ± 0.09c 2.88 ± 0.16ab
Fecal total sterol excretion (μmol/[d 100 g body wt]) 6.45 ± 0.43a 10.18 ± 0.33b 11.06 ± 0.48b 18.89 ± 0.40c
Means ± SEM (n = 11-12). Means within the same row having different superscripts are significantly different (P < .05).
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The magnitude of change was much greater for liver es-
terified cholesterol (mean range, 0.18-8.07 μmol/g) than 
for liver free cholesterol (5.03-9.67 μmol/g). No signifi-
cant differences were found in liver phospholipid con-
centration among any of the treatment groups.
Cholesterol absorption was significantly reduced in 
hamsters fed 1.0% PSE and 5.0% PSE compared to con-
trols (Table 4). Consistent with reduced cholesterol ab-
sorption, fecal neutral sterol excretion was increased 
in hamsters fed PSE; fecal neutral sterol excretion was 
about 4 times greater in the 5.0% PSE group compared 
to controls (0.0% PSE). Fecal neutral sterol excretion in 
hamsters fed 0.5% PSE and 1.0% PSE was about 2 times 
greater compared to controls. Fecal bile acid excretion 
was also affected by dietary PSE, although bile acid out-
put was quantitatively less then neutral sterol excretion. 
When fecal bile acid and neutral sterol were combined, 
total sterol excretion was significantly increased in all 
treatment groups relative to controls, and was directly 
correlated with PSE intake (r = 0.936, P < .001).
3.2. Study 2
Body weight gain and food intake were not significantly 
different among treatment groups. The overall mean 
body weight at the end of the study was 117 ± 1 g, and 
food intake was 6.8 ± 0.1 g/d.
Plasma non-HDL cholesterol concentration in ham-
sters fed the 5% PSE diet was significantly reduced by 
79% compared to controls (Table 5). Non-HDL choles-
terol concentration in the 3% PS + 2% SA group was also 
reduced (P < .05), but to a lesser extent (52%). Plasma 
HDL cholesterol concentration was significantly lower 
in hamsters fed 5% PSE and 3% PS + 2% SA, although 
the magnitude of reduction (24%-26% compared to con-
trols) was less than the changes in non-HDL cholesterol. 
Significant reductions in liver free and esterified choles-
terol were observed in the 5% PSE and 3% PS + 2% SA 
groups compared to controls; esterified cholesterol was 
reduced 93% to 97%. Reductions in liver weight were 
also observed in hamsters fed 5% PSE and 3% PS + 2% 
SA. Liver weight was directly correlated with liver es-
terified cholesterol concentration (r = 0.82, P < .001) 
when all data were plotted, suggesting that changes in 
liver weight were mainly due to the esterified choles-
terol content. Liver phospholipid concentration was not 
significantly different in any of the treatments.
Fecal neutral sterol excretion in hamsters fed the 
5% PSE and 3% PS + 2% SA diets was significantly in-
creased compared to controls (Table 6). Although fe-
cal bile acid excretion was significantly lower in ham-
ster fed 5% PSE and 3% PS + 2% SA, bile acid excretion 
represented less than 8% of total sterol excretion in these 
groups. Consequently, fecal total sterol excretion was 
increased 177% and 144% in the 5% PSE and 3% PS + 2% 
SA groups, respectively.
4. Discussion
Consumption of PSE is known to reduce plasma LDL 
cholesterol concentration by inhibiting intestinal choles-
terol absorption [3, 5]. Commercially available PSE are 
usually prepared by esterifying free sterols to fatty ac-
ids from edible plant oils (eg, canola, soybean, and sun-
flower), thus resulting in sterol esters containing high 
proportions of unsaturated fatty acids. We recently re-
ported that PSE enriched with SA, compared to linoleic 
acid, were significantly more effective in reducing intes-
tinal cholesterol absorption and plasma non-HDL and 
liver cholesterol concentration in hamsters [9]. This re-
search extends these findings in hamsters by testing the 
dose response of PSE containing fatty acids from beef 
tallow, a natural and abundant source of SA. Our find-
ings demonstrate dose-dependent reductions in choles-
Table 5. Plasma cholesterol, liver weight, and liver lipid concentration in hamsters fed diets containing PS esterified with fatty acids from beef 
tallow (PSE) or free PS and free SA, study 2
 0% PSE 5% PSE 3% PS + 2% SA
Non-HDL cholesterol (mmol/L) 2.79 ± 0.13c 0.59 ± 0.05a 1.34 ± 0.33b
HDL cholesterol (mmol/L) 1.78 ± 0.07b 1.36 ± 0.05a 1.31 ± 0.14a
Liver weight (g/100 g body wt) 3.40 ± 0.10b 3.04 ± 0.06ab 2.97 ± 0.13a
Liver free cholesterol (μmol/g) 8.34 ± 0.17c 4.57 ± 0.12a 5.75 ± 0.29b
Liver esterified cholesterol (μmol/g) 27.00 ± 1.80b 0.85 ± 0.09a 1.88 ± 0.26a
Liver phospholipid (μmol/g) 24.0 ± 0.5 21.3 ± 0.5 24.0 ± 2.6
Means ± SEM (n = 8). Means within the same row having different superscripts are significantly different (P < .05).
Table 6. Fecal sterol excretion in hamsters fed diets containing PS esterified with fatty acids from beef tallow (PSE) or free PS and free SA, 
Study 2
 0% PSE 5% PSE 3% PS + 2% SA
Fecal neutral sterol excretion (μmol/[d 100 g body wt]) 3.88 ± 0.13a 14.90 ± 0.75b 13.03 ± 0.98b
Fecal bile acid excretion (μmol/[d 100 g body wt]) 1.91 ± 0.17b 1.12 ± 0.27a 1.09 ± 0.08a
Fecal total sterol excretion (μmol/[d 100 g body wt]) 5.79 ± 0.27a 16.02 ± 0.88b 14.12 ± 1.00b
Means ± SEM (n = 8). Means within the same row having different superscripts are significantly different (P < .05).
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terol absorption and concurrent increases in fecal sterol 
excretion, thus resulting in lower plasma and liver cho-
lesterol concentrations.
Total sterol excretion was directly correlated with 
PSE intake (r = 0.936, P < .001). In addition, liver choles-
terol concentration was also correlated with PSE intake 
(r = −0.591, P < .001), indicating that PSE promoted an 
increased flux of liver cholesterol into the biliary path-
way for excretion. However, plasma non-HDL choles-
terol was not linearly related with PSE intake and was 
significantly reduced only in hamsters fed 5.0% PSE. 
These observations suggest that reductions in liver cho-
lesterol may have been compensated for by increased 
hepatic cholesterol synthesis, thus maintaining hepatic 
lipoprotein secretion into plasma. Our previous study 
[9] demonstrated that, depending on the fatty acid com-
position of PSE, significant changes in both liver choles-
terol concentration and fecal sterol excretion can occur 
without altering the non-HDL cholesterol concentra-
tion. We speculate that the limits of this compensatory 
response were exceeded only at the highest level of di-
etary PSE used in the present study.
Clinical studies have established that PS intakes of 1 
to 3 g/d reduce plasma LDL cholesterol concentration 
up to 15% and that higher intakes have little added in-
fluence [2, 3]. Most human studies included PSE made 
with fatty acids from unsaturated plant oils, although 
the contribution of the fatty acid moiety to the choles-
terol-lowering ability of PSE has been vastly understud-
ied. We recently reported that PSE containing 97% SA or 
beef tallow fatty acids (19% SA, 2% linoleic acid) reduced 
plasma non-HDL cholesterol to a significantly greater ex-
tent than PSE containing soybean oil fatty acids (3% SA, 
60% linoleic acid) [9]. Our previous results also indicated 
that PSE enriched with SA reduced cholesterol absorp-
tion and liver cholesterol concentration, and increased 
fecal cholesterol excretion to a greater extent than PSE 
deficient in SA [9]. Only 1 other study has directly com-
pared PSE preparations differing in their fatty acid com-
position. AbuMweis et al [13] reported that human be-
ings consuming PSE made with fish oil or sunflower oil 
fatty acids had no significant differences in plasma tri-
glyceride, LDL, or HDL cholesterol concentration. Both 
PSE preparations contained a high proportion of polyun-
saturated fatty acids and relatively little SA [13].
Beef tallow is a rich source of SA, containing about 
19% SA by weight [14]. Studies examining plasma LDL 
cholesterol concentration have demonstrated choles-
terol-lowering properties of dietary beef tallow com-
pared to soybean oil [15], coconut oil [16], butter fat 
[17], and palm and palm kernel oil [18]. Studies have 
also shown beef tallow to elicit equivalent or “neu-
tral” effects on LDL cholesterol levels compared to saf-
flower oil [16], high-oleic sunflower oil [19], and chicken 
fat [20]. Newbold [21] reported that hypercholester-
olemic patients who consumed diets in which most of 
the calories came from beef fat (and no sucrose, milk, 
or grains) had significant reductions in serum triglycer-
ide and total cholesterol levels (35% and 28% decrease, 
respectively). The pioneering studies by Keys et al [22] 
and Hegsted et al [23] indicated that SA, a major com-
ponent of beef tallow, is distinctly different than other 
saturated fatty acids (ie, palmitic, myristic, and lauric) 
because SA does not elevate serum cholesterol when 
consumed. Numerous studies have since confirmed the 
cholesterol-lowering or neutral effects of SA compared 
to other dietary fatty acids [24, 25]. Although current di-
etary recommendations encourage individuals to limit 
saturated fat intake [4, 26], the American Heart Associ-
ation acknowledges that SA is unique among the com-
mon dietary saturated fatty acids because of its choles-
terol-lowering or neutral properties, but that “there is 
no simple means of incorporating this information into 
dietary guidelines” [26].
Stearic acid elicits its hypocholesterolemic effects by 
reducing intestinal cholesterol absorption [11, 27–30], ac-
companied by increased fecal cholesterol excretion [11, 
31, 32]. Plant sterols also inhibit cholesterol absorption 
[33–35]. Because the extent of PSE hydrolysis in the small 
intestine remains uncertain [36, 37], we included a treat-
ment group in the present study in which hamsters were 
fed free PS and free SA compared to PSE (study 2). Com-
pared to PSE, consumption of a combination of free ste-
rols and free SA produced a much smaller decrease in 
non-HDL cholesterol concentration, suggesting that the 
observed cholesterol lowering may be the result of mul-
tiple mechanisms involving intact PSE, free PS, and/or 
free SA. We recently reported that free PS have the abil-
ity to displace cholesterol from micelles in vitro [38], sug-
gesting an intralumenal mechanism that would likely 
decrease cholesterol solubility and absorption in vivo. 
The extent to which PSE incorporate into micelles has 
not been reported. We also reported that intestinal FHs 
74 Int cells incubated with SA, compared to palmitic 
acid, had significantly reduced gene expression of the 
cholesterol transporter Niemann-Pick C1 Like 1, indicat-
ing intracellular regulation of cholesterol absorption by 
SA [39]. Whether PS and SA act through independent or 
synergistic mechanisms will require further study.
In conclusion, our results indicate that consump-
tion of PSE containing beef tallow fatty acids decreases 
cholesterol absorption, decreases liver and plasma 
cholesterol concentration, and increases fecal choles-
terol excretion. Consumption of PSE was more effec-
tive at reducing plasma non-HDL cholesterol concentra-
tion compared to molar equivalents of free PS and free 
SA. Our findings support the use of dietary PSE con-
taining beef tallow fatty acids in the management of 
hypercholesterolemia.
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